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Background: Drug use during pregnancy may be dangerous to the fetus. There is high consumption of prescribed
drugs among pregnant women. This condition may be much higher in developing countries. There is no sufficient
evidence on prescribed drug use among pregnant women in Bahir Dar town. The aim of this study was to assess
the level of prescribed drug use and associated factors among pregnant women attending antenatal care (ANC)
service at government health centers in Bahir Dar city administration.
Methods: Institution based cross sectional study was used. Data were collected from randomly selected 510
pregnant women. Data were analyzed using SPSS version 16.0. Back ward stepwise logistic regression model was
used and p-values <0.05 were considered statistically significant.
Result: A total of 510 pregnant women were included in the study of which 88.4% were prescribed at least one
drug during pregnancy. Nearly 11% of the pregnant women were prescribed with drugs from category D or X of
the US-FDA risk classification.
Prescribed drug use among pregnant women was more likely when the pregnancy is wanted, (AOR = 2.4, 95%
CI: 1.3 - 4.6), if the mother had maternal illness (AOR = 8.5, 95% CI: 5.4-13.4), when the educational level of ANC
provider is diploma (AOR = 2.7, 95% CI: 1.5-4.7) and when number of pregnancies is more (AOR =2.1, 95% CI:
1.3-3.3).
Conclusion: Prescribed drug use including those with potential harm to the fetus during pregnancy was very
high in Bahir Dar city administration. Prescribed drug use is more when the woman had illness, when the
woman was multi gravida and when the educational level of ANC provider was low (diploma). It is important to
upgrade providers’ educational level and institute prevention of diseases like malaria to reduce the level of
prescribed drug use during pregnancy.
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Drug utilization during pregnancy may be unnecessary
and dangerous for the fetus [1,2]. The health care
provider must be aware of appropriate pharmacologic
therapy for a variety of conditions and the potential im-
pact on pregnant women and their fetus [3,4]. To guide
safe drug use during pregnancy, the U.S. Food and
Drug Administration (FDA) classified drugs into five* Correspondence: abejegedefaw@gmail.com
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and X indicating evidence of risk in pregnancy [5,6].
Globally, information on the use of drugs during
pregnancy is scarce. Available few studies on the safety
and effectiveness of drugs for pregnant women show
that physicians prescribe, and pregnant women take a
surprisingly large number of drugs. An international in-
vestigation done in four continents showed that preg-
nant women ingest an average of three prescription
medications during their pregnancy and 86% of the
women had taken at least one prescription medication
during their pregnancies [7]. A study done on drug useal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ported that 71.3% of the pregnant women used at least
one drug during their pregnancy. In this study, nearly
4% of the pregnant women were prescribed drugs from
category D or X of the US FDA risk classification [8].
The majority of women in Ethiopia live with poor ac-
cess to health care and the situation of inappropriate
drug utilization could be worse. There is no drug pre-
scription guideline for pregnant women in Ethiopia.
Data on prescribed drug use among pregnant women
in Bahir Dar city administration is lacking. Therefore,
this study was conducted to assess the level of pre-
scribed drugs use among pregnant women in Bahir Dar
city administration and identify factors associated with
prescribed drug use.
Methods
The study was conducted in Bahir Dar city administra-
tion, Northwestern part of Ethiopia. The projected
population of Bahir Dar city administration was 239,721
for the year 2012 [9].
Institution based cross-sectional study was conducted
from June 20 – July 10, 2013 in government health cen-
ters. All pregnant women who came for ANC services to
the selected health centers during the study period were
study populations.
Pregnant women at any gestational age who were fol-
lowing the ANC service at the selected health centers
were included in the study. But pregnant women who
were referred from other health institutions outside
Bahir Dar city administration were excluded from the
study. Pregnant mothers who came more than once dur-
ing the study period were interviewed only once at their
first visit. A woman is said to have used prescribed drug
if she reported using prescribed drug during her current
pregnancy.
Sample size was determined using single population
proportion formula [10] considering proportion of drug
use during pregnancy 71.3% [8], 5% margin of error and
design effect of 1.5. After adding 10% non-response rate,
the final sample size was 518. Multistage random sam-
pling method was used to select the required number of
pregnant mothers. Health centers were stratified as rural
and urban. Then, two rural and three urban health cen-
ters were selected by lottery method. Finally, propor-
tional numbers of pregnant women were taken from
each health center based on the flow of pregnant women
per day calculated from previous month’s ANC record.
Systematic random sampling method was used to select
the pregnant women in each health facility.
Data were collected by semi-structured questionnaires
and reviews of antenatal follow up cards of pregnant
women. First, women were interviewed when she was at
waiting room. Then exit interview was done to know thetype of drug she was prescribed. Finally, her ANC chart
was reviewed to know drugs prescribed previously.
Nurses who worked in ANC rooms in other health cen-
ters and who had data collection experience collected
the data.
The data extraction forms were used to collect infor-
mation on the total number of ANC visits, gestational
age and drugs prescribed during each trimester. The
semi-structured questionnaire was used to collect socio-
demographic data, obstetric and medical history of preg-
nant women.
Data were entered in to Epi-info 3.5.2 and analyzed
using SPSS version 16.0. Bivarate analyses were per-
formed and variables with p < 0.2 were included in mul-
tivariable logistic regression using backward stepwise
logistic regression model. Hosmer and Lemeshow good-
ness of fit test was used to check model significance and
p < 0.05 was used to determine statistical significance.
Ethical clearance was obtained from Research Ethics
Review Committee of Bahir Dar University. Permission
to conduct the study was obtained from Amhara Region
Health Bureau, Bahir Dar city health office and the re-
spective health centers. Data collection was conducted
after explaining the purpose of the study to the partici-
pants and obtaining informed verbal consent.
Results
A total of 510 (response rate of 98.5%) pregnant women
were studied.
Socio demographic characteristics
The majority of the respondents (77.5%) were in the age
group of 20 and 34. The mean (±SD) age of women was
26.5 (±6.0) years. Four hundred sixty eight (91.8%) re-
spondents were married and 40(7.8%) were single.
Regarding their educational status, 151(29.6%) women
were unable to read and write, while 37 (7.3%) of them
were able to read and write. One hundred eight (21.2%)
completed primary education, 103(20.2%) had completed
secondary school, while 111 (21.8%) had attended higher
level education (Table 1).
Obstetric and medical history
Sixty five (12.7%) of the pregnant women reported his-
tory of chronic disease. More than half of the pregnant
women (54.3%) were primigravida and the rest 233
(45.7%) were multi-gravida. Three hundred sixty two
(71%) of the pregnancies were wanted, 78(15.3%) were
mistimed and 70 (13.7%) were unwanted pregnancies.
Forty three (8.4%) respondents reported history of
hospitalization during their current pregnancy. Three
hundred ninety nine (78.2%) of the respondents had 1–2
total ANC visits, and 111 (21.8%) of them had 3–4 total
ANC visits on the date of interview.
Figure 1 Percentage of commonly prescribed class of drugs to pregnant
June 20-July10, 2013 Ethiopia. Others include: - antispasmodics, laxatives, ant
Table 1 Socio-demographic characteristics of pregnant
women attending ANC Service in Bahir Dar city
administration, June 20 - July 10, 2013, Northwest
Ethiopia
Variable Number of women Percent
Age in years
≤ 19 49 9.6
20-34 395 77.5
35 – 42 66 12.9
Occupation
Government employed 92 18
NGO employed 49 9.6
Merchant 97 19





< 800.00 118 23.1
801 – 1000.00 151 29.6
1001- 2000.00 168 32.9
>2000.00 73 14.3
*House servant and daily laborer.
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A total of 451(88.4%) pregnant women were prescribed
at least one drug during their current pregnancy. Among
these, three hundred fifteen (61.8%) were prescribed at
least one drug excluding iron. The mean number of
drugs prescribed during pregnancy was 2.3. For the
current pregnancy, 103(22.8%), 166(36.8%), 128(28.4%),
43(9.5%), 8(1.8%) and 3(0.7%) women were prescribed
one, two, three, four, five and six drugs respectively.
Thirty three different types of drugs (a total of 1049)
were prescribed for the respondents.
The most commonly prescribed classes of drugs dur-
ing first trimester of pregnancy were anti-anemic. Con-
sidering all trimesters, the most commonly prescribed
and recorded class of drugs during pregnancy was anti-
anemic preparations (see Figures 1 and 2).
The most frequently prescribed category of drugs dur-
ing the first trimester were US FDA category A drugs.
Similarly, during the second trimesters, US FDA cat-
egory B drugs were the most frequently prescribed
drugs. Considering all trimesters of pregnancy, US FDA
category A drugs were the most frequently prescribed.
The frequently prescribed drugs include iron/fefol, from
US FDA category A and paracetamol and amoxicillin
from US FDA category B drugs. Fifty six (5.3%) of all the
prescribed drugs were from US FDA category D. Thewomen attending ANC service in Bahir Dar city administration,
i-protozoa, vitamins cough syrups, ant-hypertensive and anti-asthmatics.
Figure 2 Category of drugs prescribed according to US FDA risk category and gestational age among pregnant women attending ANC
service in Bahir Dar city administration June 20-July10, 2013, Ethiopia.
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category D or X drug were 10.8%. US FDA Category D or
X drugs were prescribed during all trimester of pregnancy
with the highest frequency during the second trimester.
Drugs in US FDA category D or X which were commonly
prescribed include quinine and co-trimoxazole (trimetho-
prim + sulphamethoxazole) (Figures 2 and 3).
Factors associated with prescribed drug use during
pregnancy
Multivariable logistic regression model revealed that only
pregnancy status, maternal illness on the date of interview,
educational level of provider and number of gravida wereFigure 3 Percentage of pregnant women exposed to drugs according
service in Bahir Dar city administration June 20-July10, 2013 GC, Ethisignificantly associated with prescribed drug use during
pregnancy.
Multi gravida women were 2.1 (AOR = 2.1, 95% CI:
1.3-3.3) times more likely to get drugs prescribed com-
pared to primigravida women. Pregnant women with
current illness were 8.5 (AOR = 8.5, 95% CI: 5.4-13.4)
times more likely to get a drug prescribed than those
who had no current maternal illness. Pregnant women
with wanted pregnancy were 2.4 (AOR 2.4, 95% CI:
1.3 -4.6) times more likely to get a drug prescribed than
those with unwanted pregnancies. Similarly, pregnant
women who were provided ANC by diploma holders
were 2.7 (AOR = 2.7, 95% CI: 1.5-4.7) times more likelyto US FDA risk category among pregnant women attending ANC
opia.
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were provided ANC by degree holders (Table 2).Discussion
In this study, a total of 451(88.4%) pregnant women
were prescribed with at least one drug during their
current pregnancy. Excluding iron only prescription, 315
(61.8%) of the pregnant women were prescribed at leastTable 2 Factors associated with prescribed drug use during p
in Bahir Dar city administration Northwest Ethiopia, June 20-
Variable Drugs prescribed
Yes No




Educational level of women
No formal education 137 51
Attained formal education 178 144




















Number of ANC visits
1-2 239 160
3-4 76 35
Location of health facility
Urban 222 161
Rural 93 34one drug. A total of 56(10.8%) pregnant women were
prescribed drugs from US FDA category D or X.
In this study, the proportion of pregnant women who
were prescribed drugs (88.4%) was higher than a study
done in Addis Ababa which revealed that 71.3% of the
respondents took at least one drug during their preg-
nancy [8]. This relatively higher extent of drug use may
be due to the implementation of iron/fefol supplementa-
tion policy. This finding was similar to studies in Norway,regnancy among pregnant women attending ANC service
July10, 2013
COR, 95% CI AOR, 95% CI
P-value
1 1








2.3(1.3 – 4.1) 2.1(1.3-3.3)
2.0 (1.2 -3.4 ) 2.4(1.3 -4.6 ) 0.006
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a study in Hungary (92%) and Brazil (94.9%) [2,13].
The most commonly prescribed drugs to pregnant
women in this study were anti-anemic followed by anal-
gesic, anti-microbial, anti-malaria and antacids. This was
consistent with the study done in Addis Ababa and
Pakistan [8,14]. The reason is that anemia, head ache
and gastritis are the common physiologic problems dur-
ing pregnancy.
This study indicated that US FDA category A drugs
were the most frequently prescribed drugs during preg-
nancy followed by US FDA category B, C, D or X. The
proportion of women prescribed with US FDA risk cat-
egory D drug during their pregnancy in this study was two
times higher than findings in US, Pakistan and Addis
Ababa. A study in USA using data from eight health main-
tenance organizations showed that 4.8% of pregnant
women received a drug from category D [15]. Another
study conducted to evaluate patterns of drug prescriptions
to pregnant women in tertiary care hospitals in Pakistan
showed that 2.3% of drugs prescribed to pregnant women
were considered to be teratogenic and twenty nine preg-
nant women (0.8%) were prescribed these teratogenic
drugs [14]. Similarly a study done in Addis Ababa indi-
cated that nearly 4% of pregnant women were prescribed
from category D or X [8].
The proportion of pregnant women prescribed US FDA
category D or X drugs were 10.8% which is not compar-
able to the findings of a study conducted in Addis Ababa
(8). But this finding was comparable with a study done in
Nigeria, which showed that 13% of pregnant mothers were
prescribed from category D [16].
Among the 56 drugs prescribed from US FDA category
D or X drugs, 49(87.5%) were quinine tablets prescribed to
treat malaria. This is high compared to finding of a study
in Addis Ababa. The reason for this difference is high
prevalence of malaria in Bahir Dar city administration. The
other US FDA category D drugs prescribed to pregnant
women include doxycycline and co-trimoxazole (trimetho-
prim and sulphamethoxazole combination). Among the
category D drugs prescribed in this study, co-trimoxazole
was mentioned in a study done in Addis Ababa [8].
Our findings indicated that there is significant associ-
ation between drugs prescribed during pregnancy and gra-
vidity, maternal illness on the date of interview, pregnancy
status and educational level of the provider. These find-
ings are comparable to other studies [2,8,17]. The reason
for this may be as number of pregnancy increases, risk of
maternal illness increases. Similarly, as educational level of
the provider increases, the probability of prescribing many
drugs will decrease.
There was a possibility of recall bias while trying to
gather data on previous medical and drug use history.
This was minimized through the use of multiple datasources as interview, and medical records to check for
the previous drugs used.
Conclusions
The level of prescribed drug use including those with
potential harm to the fetus during pregnancy was very
high in Bahir Dar city administration. The prescribed
drug use during pregnancy was higher when the preg-
nancy was wanted, if the mother had illness on the date
of interview, when the educational level of provider is
low (diploma) and when the woman is multi gravida.
Therefore, it is essential to upgrade health professionals
who are providing ANC service from Diploma to Degree
level to reduce the risk of prescribing unnecessary drugs
to pregnant women. Malaria prevention methods should
be also strengthened as anti malarial drugs are the most
frequently prescribed category D or X drugs to the preg-
nant women in this study. Food, medicine and health
care administration and control authority of Ethiopia
should develop guidelines that guide drug prescription
for pregnant women. We also recommend further study
to identify factors associated with category D or X drug
prescription with larger sample size.
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